Clinical Trial

Trial Protocol ID USOR 22026_MK3475-587

Trial Description

A Multicenter, Open-label, Phase 3 Study to Evaluate the Long-term Safety and Efficacy in Participants who are Currently on Treatment or in Follow-up in Studies That Include Pembrolizumab

View on ClinicalTrials.gov

Contact us regarding Clinical Trials at MOHRSCH@usoncology.com or call us at 877-664-7724

Investigator

  • Andrew Mener, MD

Disease Types

Sponsor

  • Merck Sharp & Dohme Corp.

ClinicalTrials.gov NCT ID

  • NCT03486873